title: Structure-activity studies for a novel series of N-(arylethyl)-N-(1,2,3,4-tetrahydronaphthalen-1-ylmethyl)-N-methylamine s possessing dual 5-HT uptake inhibiting and alpha2-antagonistic activities.
abstract: In search of an alpha2-antagonist/5-HT uptake inhibitor as a potential new class of antidepressant with a more rapid onset of action, compound 3 was prepared and observed to possess high affinity for the alpha2-receptor (K(i) = 6.71 nM) and the 5-HT uptake site (20.6 nM). A series of tertiary amine analogs of 3 were synthesized and assayed for their affinity at both the alpha2-receptor and the 5-HT uptake site. The structure-activity relationship reveals that a variety of structural modifications to the arylethyl fragment are possible with retention of this dual activity. On the tetralin portion, 5-OMe substitution and the (R) stereochemistry at C-1 are optimal with alternate substitutions producing compounds retaining high affinity for the alpha2-receptor but lacking affinity for the 5-HT uptake site. Data for several rigidified 5-O-alkyl analogs suggests that the favored orientation of the oxygen lone pairs may be away from the 6-position of the tetralin.
authors.affiliation: Neuroscience Research, Department 47C, Pharmaceutical Products Division, Abbott Park, Illinois 60064, USA.
authors.forename: M D
authors.initials: MD
authors.lastname: Meyer
authors.forename: A A
authors.initials: AA
authors.lastname: Hancock
authors.forename: K
authors.initials: K
authors.lastname: Tietje
authors.forename: K B
authors.initials: KB
authors.lastname: Sippy
authors.forename: R
authors.initials: R
authors.lastname: Prasad
authors.forename: D M
authors.initials: DM
authors.lastname: Stout
authors.forename: D L
authors.initials: DL
authors.lastname: Arendsen
authors.forename: B G
authors.initials: BG
authors.lastname: Donner
authors.forename: W A
authors.initials: WA
authors.lastname: Carroll
mesh_terms: D058669:Adrenergic alpha-2 Receptor Antagonists; D000317:Adrenergic alpha-Antagonists / Q000737:chemistry* / Q000494:pharmacology; D000818:Animals; D002540:Cerebral Cortex / Q000187:drug effects / Q000378:metabolism; D009682:Magnetic Resonance Spectroscopy; D008744:Methylamines / Q000737:chemistry* / Q000494:pharmacology; D051381:Rats; D017367:Selective Serotonin Reuptake Inhibitors / Q000737:chemistry* / Q000494:pharmacology; D013237:Stereoisomerism; D013329:Structure-Activity Relationship
chemical_list: D058669:Adrenergic alpha-2 Receptor Antagonists; D000317:Adrenergic alpha-Antagonists; D008744:Methylamines; D017367:Selective Serotonin Reuptake Inhibitors